• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Ellen M Lavoie Smith, Herbert Pang, +9 authors Charles L. Shapiro
  • Medicine
  • JAMA
  • 2013 (First Publication: 3 April 2013)
  • IMPORTANCE There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy. OBJECTIVE To determine the effect of duloxetine, 60 mg daily, on average pain severity. Continue Reading
  • Charles L Loprinzi, Brandi N. Reeves, +9 authors Daniel H. Lachance
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2011 (First Publication: 10 April 2011)
  • PURPOSE The characteristics and natural history of the paclitaxel-acute pain syndrome (P-APS) and paclitaxel's more chronic neuropathy have not been well delineated. METHODS Patients receivingContinue Reading
  • Brandi N. Reeves, Shaker R. Dakhil, +10 authors Charles L Loprinzi
  • Medicine
  • Cancer
  • 2012 (First Publication: 15 October 2012)
  • BACKGROUND Paclitaxel causes an acute pain syndrome (P-APS), occurring within days after each dose and usually abating within days. Paclitaxel also causes a more classic peripheral neuropathy, whichContinue Reading
  • Krishna Patel, Nathan R. Foster, +6 authors Aminah Jatoi
  • Medicine
  • Journal of Cancer Education
  • 2013 (First Publication: 1 December 2013)
  • Oncologists are now prescribing more oral chemotherapy than ever before, thus placing the onus for taking the right dose at the right time under the right circumstances directly on the patient. ThisContinue Reading
  • E.M.L. Smith, Herbert Pang, +9 authors Cl Shapiro
  • Medicine
  • European journal of cancer care
  • 2017 (First Publication: 1 March 2017)
  • Duloxetine is an effective treatment for oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN). However, predictors of duloxetine response have not been adequately explored.Continue Reading
  • Debra L. Barton, Pamela J. Atherton, +10 authors Charles L Loprinzi
  • Medicine
  • The journal of supportive oncology
  • 2011
  • Sleep disorders are a substantial problem for cancer survivors, with prevalence estimates ranging from 23% to 61%. Although numerous prescription hypnotics are available, few are approved forContinue Reading